News

Transatlantic Exchanges: Artificial Intelligence in Oncology on the Program

Join us on May 5th in Paris for a high-level exchange day dedicated to artificial intelligence in oncology, organized by two leaders in the fight against cancer, the Dana-Farber Cancer Institute (United States) and Gustave Roussy.

Published on

Changed on

Join us on May 5th in Paris for a high-level exchange day dedicated to artificial intelligence in oncology, organized by two leaders in the fight against cancer, the Dana-Farber Cancer Institute (United States) and Gustave Roussy.

One year after the success of the first edition in 2022 on the theme of immuno-oncology, the Transatlantic Exchanges are back.

Ranked respectively 3rd and 4th best cancer hospitals in the world, Gustave Roussy and the Dana-Farber Cancer Institute are organizing the second edition of this scientific conference on Artificial Intelligence and Data Science in Oncology, supported by the Servier Institute and broadcast live on the Medscape platform. The objective is to share knowledge and advancements on a rapidly evolving subject.

High-level speakers

This one-day session is co-chaired by Professor Toni Choueiri, director of the Lank Center for Genitourinary Oncology at the Dana-Farber Institute, and Professor Karim Fizazi, medical oncologist and head of the international academic network at Gustave Roussy. The conference will be moderated by Professor Fabrice André, director of research at Gustave Roussy. Among the expected speakers are Eliezer Van Allen, physician, head of the division of population sciences, Professor Franziska Michor, professor of computational biology at the Dana-Farber, and Professor Paul Henry Cournède, director of research at CentraleSupélec, Paris-Saclay University.

The event, which will take place at the Boissière Conference Center in Paris, is open to all healthcare professionals interested in prior registration. Register to participate in-person on the day.

It will also be virtually broadcast on the Medscape platform. Register here.

This program is part of a collaboration agreement between the Dana-Farber Cancer Institute and Gustave Roussy, supported by the Servier Institute. It includes annual conferences alternating between Boston and Paris, as well as a scholarship program for young researchers from Gustave Roussy, who will be hosted in the research laboratories of the Dana-Farber.

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin